Inhibikase Therapeutics, Inc. (IKT) is a biotechnology company focused on developing novel therapies for neurodegenerative diseases, including Parkinson’s disease and other related disorders. The company’s key product is IkT-148009, a small molecule drug that targets a protein called alpha-synuclein, which is believed to play a critical role in the progression of Parkinson’s disease and similar […]
Read MoreInMed Pharmaceuticals Inc. (INM) is a biopharmaceutical company specializing in the development of cannabinoid-based therapies to address unmet medical needs. Unlike companies that focus on recreational cannabis, InMed focuses on pharmaceutical applications of cannabinoids, leveraging their therapeutic potential for treating a range of conditions. Their work involves using rare cannabinoids, which are naturally occurring compounds […]
Read MoreThe biopharmaceutical and biotechnology sector continues to make significant strides in developing therapies and medical advancements. Companies like Mesoblast Limited (MESO), Nurix Therapeutics, Inc. (NRIX), and Eledon Pharmaceuticals, Inc. (ELDN) are driving innovation in treatments for complex diseases, utilizing advanced scientific approaches to improve patient outcomes. Mesoblast Limited (MESO) is a biopharmaceutical company focused on […]
Read MoreFeatured Content The cannabis sector is evolving rapidly as companies like Flora Growth Corp. and Aurora Cannabis Inc. continue to expand in both consumer products and medical marijuana. Both companies are positioned to benefit from the growing acceptance and legalization of cannabis worldwide, while facing unique challenges and opportunities in their respective markets. Flora Growth […]
Read MoreFeatured Content Protagonist Therapeutics, Inc. (PTGX) is a biopharmaceutical company focused on developing novel therapies for patients with serious diseases. The company specializes in creating peptide-based therapeutics, leveraging its proprietary technology to develop drugs that target specific biological pathways. Protagonist is primarily engaged in advancing treatments for hematologic malignancies, autoimmune diseases, and other conditions where […]
Read MoreFeatured Content Innoviva, Inc. (INVA) is a biopharmaceutical company that focuses on the development and commercialization of innovative therapies to treat respiratory diseases and other medical conditions. Founded in 1996, Innoviva aims to improve the quality of life for patients through advanced therapeutic solutions. The company leverages strategic collaborations and partnerships to enhance its product […]
Read MoreGyre Therapeutics, Inc. (GYRE) Gyre Therapeutics, Inc., a pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis. Candel Therapeutics, Inc. (CADL) Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. Jasper Therapeutics, Inc. (JSPR) Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops […]
Read MoreQ32 Bio Inc. is a biotechnology company focused on developing therapies to treat severe autoimmune and inflammatory diseases. The company leverages its deep understanding of immune system biology to create novel treatments that address the underlying causes of these debilitating conditions. Q32 Bio’s pipeline includes both antibody-based therapies and targeted cytokine inhibitors, designed to modulate […]
Read MoreHUTCHMED (China) Limited (HCM) HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in Hong Kong and internationally. Repligen Corporation (RGEN) Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. […]
Read MoreHumacyte, Inc. is a biotechnology company at the forefront of developing bioengineered human tissues and organs. The company’s proprietary technology platform focuses on creating off-the-shelf, bioengineered human tissues that can be used in a variety of medical applications, including vascular surgeries, kidney dialysis, and other conditions requiring tissue replacement. Humacyte’s key product candidate, the Human […]
Read MoreCorbus Pharmaceuticals Holdings, Inc. (CRBP) is a biopharmaceutical company focused on developing innovative therapies to address rare, chronic, and serious inflammatory and fibrotic diseases. Their main objective is to improve the lives of patients suffering from these debilitating conditions. The company’s key product, lenabasum, is an investigational drug designed to modulate the immune response, reducing […]
Read MoreHumacyte, Inc. (HUMA) Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. Nkarta, Inc. (NKTX) Nkarta, Inc., a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment. […]
Read MoreAvidity Biosciences, Inc. (RNA) Avidity Biosciences, Inc., a biopharmaceutical company, engages in the delivery of RNA therapeutics. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat diseases previously untreatable with RNA therapeutics. Jumia Technologies AG (JMIA) Jumia Technologies AG operates an e-commerce platform in West Africa, North Africa, East and South Africa, Europe, the United […]
Read MoreCorbus Pharmaceuticals Holdings, Inc. is a clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of rare, chronic, and serious inflammatory and fibrotic diseases. Their leading product candidates include anti-inflammatory and anti-fibrotic therapies that target the endocannabinoid system, aiming to provide significant therapeutic benefits for patients with limited treatment […]
Read MoreHumacyte, Inc. is a biotechnology company focused on developing and commercializing bioengineered human tissues and organs. Their primary product, the Human Acellular Vessel (HAV), is designed to address the unmet needs in vascular surgery and hemodialysis access. These bioengineered vessels aim to improve patient outcomes by offering a reliable and durable alternative to synthetic and […]
Read More